Karolinska dumps remaining BioArctic stake

April 16, 2018

Share:

Biotechnology | Stockholm, Sweden | Secondary Transaction

Life sciences investor Karolinska Development has sold its remaining holding in BioArctic for SEK 12 million (around €1.2 million). The firm had previously sold a stake in the business worth SEK 35 million in November, following the biotech's October IPO. BioArctic researches new treatments for central nervous system disorders.